Thiruvengadam SK, Popplewell LL, Herrera AF, Mei M, et al. Mosunetuzumab is effective and well tolerated in older patients with relapsed/refractory follicular lymphoma: Subgroup analysis of a phase I/II study. Br J Haematol 2025 Nov 18. doi: 10.1111/bjh.70212.
PMID: 41254806